Accessibility Menu
 
Universal Ibogaine logo

Universal Ibogaine

(OTC) IBOGF

Current Price$0.03
Market Cap$8.82M
Since IPO (2022)-58%
5 YearN/A
1 Year+53%
1 Month+129%

Universal Ibogaine Financials at a Glance

Market Cap

$8.82M

Revenue (TTM)

$1.54M

Net Income (TTM)

$1.65M

EPS (TTM)

$-0.00

P/E Ratio

-9.17

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

538,049

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.05

52-Week Range

$0.00 - $0.35

IBOGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Universal Ibogaine

Industry

Healthcare Providers and Services

CEO

Nicholas Peter Karos

Headquarters

Calgary, AB T2P 4H2, CA

IBOGF Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

25%

Net Income Margin

-35%

Return on Equity

-161%

Return on Capital

13%

Return on Assets

-9%

Earnings Yield

-10.91%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.82M

Shares Outstanding

274.83M

Volume

538.05K

Avg. Volume

1.23M

Financials (TTM)

Gross Profit

$1.07M

Operating Income

$497.15K

EBITDA

$4.61M

Operating Cash Flow

$4.33M

Capital Expenditure

$95.68K

Free Cash Flow

$4.43M

Cash & ST Invst.

$726.05K

Total Debt

$1.74M

Universal Ibogaine Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$700.92K

N/A

Gross Profit

$700.92K

N/A

Gross Margin

100.00%

N/A

Market Cap

$8.82M

N/A

Market Cap/Employee

$1.26M

N/A

Employees

7

N/A

Net Income

$66.20K

+92.1%

EBITDA

$52.88K

+107.3%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.44M

-53.2%

Accounts Receivable

$608.26K

+421.8%

Inventory

$0.00

N/A

Long Term Debt

$1.72M

+130.2%

Short Term Debt

$848.92K

-45.3%

Return on Assets

-9.25%

N/A

Return on Invested Capital

13.35%

N/A

Free Cash Flow

$110.36K

+81.4%

Operating Cash Flow

$110.36K

+75.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRTXGalera Therapeutics, Inc.
$0.09+4.56%
AAGHAmerica Great Health
$0.00+0.00%
HESGHealth Sciences Group, Inc.
$0.00+0.00%
APLIFAppili Therapeutics Inc.
$0.01-13.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
PLTRPalantir Technologies
$146.03+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$50.51+0.01%
IBITiShares Bitcoin Trust
$45.40+0.02%

Questions About IBOGF

What is the current price of Universal Ibogaine?

Universal Ibogaine is trading at $0.03 per share.

What is the 52-week range for Universal Ibogaine?

Over the past 52 weeks, Universal Ibogaine has traded between $0.00 and $0.35.

How much debt does Universal Ibogaine have?

As of the most recent reporting period, Universal Ibogaine reported total debt of $1.86M.

How much cash does Universal Ibogaine have on hand?

Universal Ibogaine reported $92,482.444 in cash and cash equivalents in its most recent financial results.

What is Universal Ibogaine’s dividend yield?

Universal Ibogaine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.